Annual Drug Patent Expirations for TIROSINT
Tirosint is a drug marketed by Ibsa and is included in two NDAs. It is available from three suppliers. There are five patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for TIROSINT.
This drug has sixteen patent family members in nine countries.
The generic ingredient in TIROSINT is levothyroxine sodium. Three suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
